Drug Type Small molecule drug |
Synonyms 6-({4-[2-(4-tert-Butylphenyl)-1H-benzimidazol-4-yl]piperazin-1-yl}methyl)quinoxaline, WAY207024 |
Target |
Mechanism GnRHR antagonists(Gonadotropin-releasing hormone receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hirsutism | Preclinical | US | 09 Mar 2009 | |
Prostatic Cancer | Preclinical | US | 09 Mar 2009 | |
Uterine Fibroids | Preclinical | US | 09 Mar 2009 |